Reference #: 01472
The University of South Carolina is offering licensing opportunities for Carrier-free curcumin nanoparticle for EGFR positive cancer therapy
Background:
Due to their small size and large surface area, drug nanoparticles show great promise in improving drug delivery in patients.
Invention Description:
Most nanoparticle based drug delivery systems are composed of a carrier and a payload. However, due to the low drug loading content, premature drug release, non-standardized or uniform carrier structure, and difficulty in predicating the fate of the carrier, only a few nanomedicines have been approved by FDA.
Potential Applications:
Cancer treatment
Advantages and Benefits:
lower toxicity, high potency, better survival rate